CLEW Receives FDA Emergency Use Authorization (EUA) for Its Predictive Analytics Platform in Support of COVID-19 Patients. CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19. from ILTV: Interview with CLEW’s CEO, Gal Salomon
Category: News
AI in Healthcare: Emergency-use authorization granted for AI-based COVID management
The FDA has cleared an AI startup based in Israel to market its predictive-analytics product to ICUs during the present pandemic. from AI in Healthcare: Emergency-use authorization granted for AI-based COVID management
CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients
CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19 from CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients
BioWorld: CLEW snags EUA for COVID-19 predictive screening tool
AI algorithms trained on large retrospective datasets from BioWorld: CLEW snags EUA for COVID-19 predictive screening tool
HIT Consultant: FDA Clears ICU Device That Predicts Respiratory Failure to Support COVID-19
CLEW is already implemented in coronavirus units in two Israeli hospitals, and being tested by several US hospitals. from HIT Consultant: FDA Clears ICU Device That Predicts Respiratory Failure to Support COVID-19
Times of Israel: Israeli tech to warn doctors before COVID-19 patients deteriorate
Physicians are struggling to draw on experience to treat the coronavirus. One Israeli company, newly authorized to deploy its tech in US hospitals, uses data and AI to help from Times of Israel: Israeli tech to warn doctors before COVID-19 patients deteriorate
nocamels: AI Medical Analytics Startup CLEW Gets Emergency FDA Nod For COVID-19 Solution
Israeli medical analytics startup Clew announced on Tuesday that it received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its ICU solution, which allows healthcare providers to help identify patients at risk of being diagnosed with respiratory failure or hemodynamic instability, two common complications associated with COVID-19. from nocamels: AI Medical Analytics Startup CLEW Gets Emergency FDA Nod For COVID-19 Solution
Contagion: FDA Issues EUA for COVID-19 Predictive Analytics Platform
Clinicians and AI researchers from CLEEW Med announced today that the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the firm’s CLEWICU system. from Contagion: FDA Issues EUA for COVID-19 Predictive Analytics Platform
Calcalist: Top Israeli Startups 2020: Most Promising MedTech Companies
Calcalist and CTech compiled a list of the most forward looking startups in this promising field, which was only strengthened by the outbreak of Covid-19 from Calcalist: Top Israeli Startups 2020: Most Promising MedTech Companies
Forbes: Israeli Innovators Harness Artificial Intelligence Technologies To Curb The Global COVID-19 Pandemic
What we know already is that scientists and researchers are working diligently to find treatments and to develop a vaccine for coronavirus. Meanwhile, artificial intelligence technologies are emerging as key solutions to combating coronavirus, and Israel is well positioned in this field. from Forbes: Israeli Innovators Harness Artificial Intelligence Technologies To Curb The Global COVID-19 Pandemic